Anson Lee Lab

Atrial fibrillation (AF) is the most prevalent arrhythmia among Americans, affecting 3-6 million people. AF represents a growing burden for our aging population and costs the United States $6 billion annually.

We are working to advance the mechanistic understanding of atrial fibrillation in order to develop potential therapies to treat it and other forms of arrhythmia. We believe that studying atrial fibrillation with basic science and clinical approaches will provide new insights into this disease and improve the lives of those who live with it.